Relationship Between Risk Factors and Brain Reserve in Late Middle Age: Implications for Cognitive Aging

Background Brain reserve can be defined as the individual variation in the brain structural characteristics that later in life are likely to modulate cognitive performance. Late midlife represents a point in aging where some structural brain imaging changes have become manifest but the effects of cognitive aging are minimal, and thus may represent an ideal opportunity to determine the relationship between risk factors and brain imaging biomarkers of reserve. Objective We aimed to assess neuroimaging measures from multiple modalities to broaden our understanding of brain reserve, and the late midlife risk factors that may make the brain vulnerable to age related cognitive disorders. Methods We examined multimodal [structural and diffusion Magnetic Resonance Imaging (MRI), FDG PET] neuroimaging measures in 50–65 year olds to examine the associations between risk factors (Intellectual/Physical Activity: education-occupation composite, physical, and cognitive-based activity engagement; General Health Factors: presence of cardiovascular and metabolic conditions (CMC), body mass index, hemoglobin A1c, smoking status (ever/never), CAGE Alcohol Questionnaire (>2, yes/no), Beck Depression Inventory score), brain reserve measures [Dynamic: genu corpus callosum fractional anisotropy (FA), posterior cingulate cortex FDG uptake, superior parietal cortex thickness, AD signature cortical thickness; Static: intracranial volume], and cognition (global, memory, attention, language, visuospatial) from a population-based sample. We quantified dynamic proxies of brain reserve (cortical thickness, glucose metabolism, microstructural integrity) and investigated various protective/risk factors. Results Education-occupation was associated with cognition and total intracranial volume (static measure of brain reserve), but was not associated with any of the dynamic neuroimaging biomarkers. In contrast, many general health factors were associated with the dynamic neuroimaging proxies of brain reserve, while most were not associated with cognition in this late middle aged group. Conclusion Brain reserve, as exemplified by the four dynamic neuroimaging features studied here, is itself at least partly influenced by general health status in midlife, but may be largely independent of education and occupation.

[1]  Y. Stern,et al.  Mechanisms underlying resilience in ageing , 2019, Nature Reviews Neuroscience.

[2]  Robert I. Reid,et al.  Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging , 2018, Annals of neurology.

[3]  M. Laubach,et al.  Size matters: Grey matter brain reserve predicts executive functioning in the elderly , 2018, Neuropsychologia.

[4]  Y. Stern,et al.  Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance , 2018, Alzheimer's & Dementia.

[5]  Prashanthi Vemuri,et al.  Resistance vs resilience to Alzheimer disease , 2018, Neurology.

[6]  Prashanthi Vemuri,et al.  Age, vascular health, and Alzheimer disease biomarkers in an elderly sample , 2017, Annals of neurology.

[7]  Luca Presotto,et al.  Gender differences in healthy aging and Alzheimer's Dementia: A 18F‐FDG‐PET study of brain and cognitive reserve , 2017, Human brain mapping.

[8]  M. Albert,et al.  Cognitive reserve and cortical thickness in preclinical Alzheimer’s disease , 2017, Brain Imaging and Behavior.

[9]  Catherine A. Macleod,et al.  Potentially modifiable lifestyle factors, cognitive reserve, and cognitive function in later life: A cross-sectional study , 2017, PLoS medicine.

[10]  C. Jack,et al.  A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity , 2016, NeuroImage: Clinical.

[11]  L. Simoni,et al.  Sex and Gender Differences in Central Nervous System-Related Disorders , 2016, Neuroscience journal.

[12]  Matthew L Senjem,et al.  Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings , 2015, Brain : a journal of neurology.

[13]  K. Yaffe,et al.  Is late-onset Alzheimer's disease really a disease of midlife? , 2015, Alzheimer's & dementia.

[14]  P. Wolf,et al.  Gender and incidence of dementia in the Framingham Heart Study from mid-adult life , 2015, Alzheimer's & Dementia.

[15]  C. Jack,et al.  Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly , 2015, Brain : a journal of neurology.

[16]  H. Johansen-Berg,et al.  Accelerated Changes in White Matter Microstructure during Aging: A Longitudinal Diffusion Tensor Imaging Study , 2014, The Journal of Neuroscience.

[17]  J. Clarimón,et al.  Cerebrospinal fluid β‐amyloid and phospho‐tau biomarker interactions affecting brain structure in preclinical Alzheimer disease , 2014, Annals of neurology.

[18]  Sterling C. Johnson,et al.  Amyloid burden and neural function in people at risk for Alzheimer's Disease , 2014, Neurobiology of Aging.

[19]  P. Vemuri,et al.  Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences , 2014, Clinical epidemiology.

[20]  Brigitte Landeau,et al.  Relationships between years of education and gray matter volume, metabolism and functional connectivity in healthy elders , 2013, NeuroImage.

[21]  Eric Guedj,et al.  Metabolic Networks Underlying Cognitive Reserve in Prodromal Alzheimer Disease: A European Alzheimer Disease Consortium Project , 2013, The Journal of Nuclear Medicine.

[22]  Yaakov Stern,et al.  Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease , 2013, Neurology.

[23]  G. Alexander,et al.  Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. , 2013, JAMA neurology.

[24]  William Jagust,et al.  Vulnerable Neural Systems and the Borderland of Brain Aging and Neurodegeneration , 2013, Neuron.

[25]  B. Yawn,et al.  History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. , 2012, Mayo Clinic proceedings.

[26]  Y. Stern Cognitive reserve in ageing and Alzheimer's disease , 2012, The Lancet Neurology.

[27]  C. Jack,et al.  Effect of lifestyle activities on alzheimer disease biomarkers and cognition , 2012, Annals of neurology.

[28]  K. Jellinger,et al.  Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature , 2012, Journal of neuropathology and experimental neurology.

[29]  B. Yawn,et al.  Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. , 2012, Mayo Clinic proceedings.

[30]  D. Glahn,et al.  Fractional anisotropy of water diffusion in cerebral white matter across the lifespan , 2012, Neurobiology of Aging.

[31]  C. DeCarli,et al.  Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline , 2011, Alzheimer's & Dementia.

[32]  Amy L. Byers,et al.  Depression and risk of developing dementia , 2011, Nature Reviews Neurology.

[33]  Warren J Manning,et al.  Cardiac Index Is Associated With Brain Aging: The Framingham Heart Study , 2010, Circulation.

[34]  Anders H. Andersen,et al.  White matter diffusion alterations in normal women at risk of Alzheimer's disease , 2010, Neurobiology of Aging.

[35]  Stephen M. Smith,et al.  Age-related changes in grey and white matter structure throughout adulthood , 2010, NeuroImage.

[36]  Y. Stern,et al.  Cognitive reserve , 2009, Neuropsychologia.

[37]  J. Pariente,et al.  Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve , 2009, Brain : a journal of neurology.

[38]  Wiro J Niessen,et al.  White matter microstructural integrity and cognitive function in a general elderly population. , 2009, Archives of general psychiatry.

[39]  Suzanne Craft,et al.  The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. , 2009, Archives of neurology.

[40]  E. Barrett-Connor,et al.  Central obesity and increased risk of dementia more than three decades later , 2008, Neurology.

[41]  V. Bellizzi,et al.  [Prevalence of chronic kidney disease]. , 2008, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia.

[42]  Diana B Petitti,et al.  Social network, cognitive function, and dementia incidence among elderly women. , 2008, American journal of public health.

[43]  V. Pankratz,et al.  The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics , 2008, Neuroepidemiology.

[44]  P. Sachdev,et al.  Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review , 2008, Current opinion in neurology.

[45]  J. Coresh,et al.  Prevalence of chronic kidney disease in the United States. , 2007, JAMA.

[46]  K. Dickstein,et al.  How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. , 2007, European heart journal.

[47]  A. Hoes,et al.  Clinical epidemiology of heart failure , 2007, Heart.

[48]  N. Schuff,et al.  Headache and cerebral venous air embolism , 2007, Neurology.

[49]  D. Preiss,et al.  Reactions to the chief medical officer's report , 2006, BMJ : British Medical Journal.

[50]  J. Traynor,et al.  How to measure renal function in clinical practice , 2006, BMJ : British Medical Journal.

[51]  K. Yaffe,et al.  Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women. , 2006, The journal of nutrition, health & aging.

[52]  R. Petersen Commentary on “Diagnosis of Alzheimer’s disease: Two decades of progress” , 2005, Alzheimer's & Dementia.

[53]  K Yaffe,et al.  Midlife cardiovascular risk factors and risk of dementia in late life , 2005, Neurology.

[54]  M. Filippi,et al.  White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging , 2002, Journal of neurology, neurosurgery, and psychiatry.

[55]  D. Goldstein,et al.  Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. , 2002, Diabetes care.

[56]  D. Le Bihan,et al.  Diffusion tensor imaging: Concepts and applications , 2001, Journal of magnetic resonance imaging : JMRI.

[57]  K. Rockwood,et al.  Alcohol Abuse, Cognitive Impairment, and Mortality Among Older People , 2001, Journal of the American Geriatrics Society.

[58]  M. Thun,et al.  Body-mass index and mortality in a prospective cohort of U.S. adults. , 1999, The New England journal of medicine.

[59]  A. Hofman,et al.  Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study , 1998, The Lancet.

[60]  R B D'Agostino,et al.  Cigarette smoking as a risk factor for stroke. The Framingham Study. , 1988, JAMA.

[61]  J. Ewing,et al.  Detecting alcoholism. The CAGE questionnaire. , 1984, JAMA.

[62]  D. Sharp,et al.  The role of the posterior cingulate cortex in cognition and disease. , 2014, Brain : a journal of neurology.

[63]  Barbara Schober,et al.  Sex and Gender Differences , 2012 .

[64]  Michèle Allard,et al.  Brain fuel metabolism, aging, and Alzheimer's disease. , 2011, Nutrition (Burbank, Los Angeles County, Calif.).

[65]  K. White,et al.  Clinical epidemiology. , 1983, International journal of epidemiology.